Pilot Studies for the Spectrum of Alzheimers Disease/Alzheimers Disease-Related Dementias and Age-Related Cognitive Decline (R61 Clinical Trial Optional) (345099)

From US Department of Health & Human Services: National Institutes of Health (NIH)

The National Institutes of Health (NIH), a part of the U.S. Department of Health and Human Services, is the nation’s medical research agency — making important discoveries that improve health and save lives.

Type of Support

Overview

The grant aims to support pilot data collection for early-stage testing of both pharmacological and non-pharmacological interventions targeting cognitive and neuropsychiatric changes stemming from age-related cognitive decline as well as Alzheimer's disease (AD) and Alzheimer's disease-related dementias (ADRD). It encourages research across the full spectrum of disease stages, from pre-symptomatic to more severe, and seeks to stimulate studies that improve trial design and methodologies.

Eligibility

Organization's Location
est aliquip
Program Location
in
Organization Type
up to 650k

Submission

Visit Apply for more information.